Enter assignee name

EPO Patents = 2

Trademarks = 2

Forward Citations = 74

Loading Chart...

8 inventors (with patents filed for the assignee):

John L Wallace (10 out of 12 patents)

Giuseppe Cirino (10 out of 13 patents)

Giuseppe Caliendo (9 out of 9 patents)

4. Vincenzo Santagada (8 out of 8 patents)

5. Anna Sparatore (6 out of 6 patents)

6. Stefano Fiorucci (5 out of 16 patents)

7. Vicenzo Santagada (1 out of 1 patent)

8. Giuseppe Caliendo (0 patent)

10 patents: Sort by Forward Citations

1. 8541398 - Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs (2013-09-24),

2. 8314140 - 4-hydroxythiobenzamide derivatives of drugs (2012-11-20),

3. 8114858 - Derivatives of 4- or 5-aminosalicylic acid (2012-02-14),

4. 8114857 - Derivatives of 4- or 5-aminosalicylic acid (2012-02-14),

5. 7910568 - Derivatives of 4- or 5-aminosalicylic acid (2011-03-22),

6. 7879827 - Derivatives of 4- or 5-aminosalicylic acid (2011-02-01),

7. 7741359 - Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs (2010-06-22),

8. 7666907 - Salts of trimebutine and N-desmethyl trimebutine (2010-02-23),

9. 7498355 - Derivatives of 4- or 5-aminosalicylic acid (2009-03-03),

10. 7326809 - Salts of 4- or 5-aminosalicylic acid (2008-02-05),

Antibe Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing safer, non-addictive pain therapeutics. Their lead drug, ATB-346, is in Phase 2b clinical trials for osteoarthritis pain. Antibe's technology aims to reduce the gastrointestinal side effects associated with traditional NSAIDs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

10 Patents

#105 in Calgary

#1,465 in Canada

#54,238 in the World

Calgary, Canada

Antibe Therapeutics Inc.